The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

24 Aug 2010 07:00

INTERSERVE APPOINTED TO £4.5bn PROCURE21+ NHS FRAMEWORK AGREEMENT

Interserve, the international services, maintenance and building group, has been named as one of the six Principal Supply Chain Partners (PCSPs) in the new ProCure21+ framework agreement, estimated to be worth up to £4.5 billion over its six-year term.

ProCure21+ will begin operating on 1st October 2010. It is a new framework that will replace the current ProCure21 programme through which Interserve has undertaken 136 schemes on behalf of 52 NHS Trusts since its pilot in 2002. Like ProCure21 the framework will streamline and improve the procurement process for NHS Trusts across England. This will enable them to select an appropriate supply chain partner to deliver acute, primary care and mental health facilities. As with ProCure21, there is a commitment to long-term relationships, collaborative working, integrated supply chains and the use of target-cost contracts.

There are a number of new features in ProCure21+ including:

* A centrally-provided risk evaluation tool for all schemes to improve

consistency and share approaches to managing common risks.

* A central repository of technical drawings and information that can be

re-used by all clients and supply-chain members under the "NHS Royalty-Free

Licence".

* An online "monthly monitoring" performance management system with a reduced

benchmarking data set to manage scheme performance centrally.

* Provision of a project start-up workshop by PCSPs on all schemes to align

stakeholder and supply chain requirements early in the process.

* Assurance of a VAT-compliant PSCP structure to maximise VAT recovery for

NHS Clients.

Commenting on Interserve's selection as a Principal Supply Chain Partner, Adrian Ringrose, Chief Executive, said, "The creation of ProCure21+ is excellent news. Under ProCure21 Interserve has been able to deliver many high-quality, value-for-money facilities and ProCure21+ will enable us to continue enhancing the health environment to meet the changing needs of the NHS. We are well positioned to do this as the only Health Framework Partner supporting the NHS across England, Scotland and Wales."

- Ends -

For further information please contact:

Amanda Cardall 0121 331 8125 Corporate Marketing Manager Elizabeth Morley / Tom Eckersley 020 7379 5151

Maitland About Interserve

Over the last five years Interserve has delivered healthcare projects with a total value of approximately £500 million, most of which has been through ProCure21.

Interserve's vision is to be the Trusted Partner of all our stakeholders. We are one of the world's foremost support services and construction companies, operating in the public and private sectors in the UK and internationally. We offer advice, design, construction and facilities management services for society's infrastructure and provide a range of plant and equipment in specialist fields. Interserve is based in the UK. It has revenue of £1.9 billion and a workforce of 50,000 people worldwide.

Health website: www.health.interserve.com

General website: www.interserve.com.

vendor
Date   Source Headline
9th Oct 20152:29 pmRNSDirector/PDMR Shareholding
7th Oct 20153:44 pmRNSDirector/PDMR Shareholding
18th Sep 20158:07 amRNSAnne Fahy appointed Non-Exec Director at SThree
14th Sep 20152:15 pmRNSDirector/PDMR Shareholding
9th Sep 20152:47 pmRNSDirector/PDMR Shareholding
4th Sep 20158:58 amRNSDirector/PDMR Shareholding
27th Aug 20159:29 amRNSPublication of Half-Year Report
25th Aug 201510:36 amRNSDirector/PDMR Shareholding
12th Aug 20152:33 pmRNSDirector/PDMR Shareholding - Correction
12th Aug 20157:00 amRNSHalf-Year Results
11th Aug 20152:31 pmRNSDirector/PDMR Shareholding
14th Jul 201512:07 pmRNSDirector/PDMR Shareholding
7th Jul 20157:00 amRNSTrading update
1st Jul 20159:46 amRNSBlocklisting Interim Review
23rd Jun 20157:00 amRNSInterserve to build Defence Rehabilitation Centre
17th Jun 201511:49 amRNSDirector/PDMR Shareholding
17th Jun 20157:00 amRNSInterserve hosts Capital Markets Day in London
2nd Jun 201512:31 pmRNSDirector/PDMR Shareholding
26th May 201511:30 amRNSDirector/PDMR Shareholding
12th May 20152:24 pmRNSResult of AGM
12th May 20157:00 amRNSTrading update
11th May 20154:04 pmRNSDirector/PDMR Shareholding
15th Apr 201511:36 amRNSDirector/PDMR Shareholding - Correction
14th Apr 201510:43 amRNSDirector/PDMR Shareholding
13th Apr 201510:51 amRNSDirector/PDMR Shareholding
1st Apr 20155:04 pmRNSDirector/PDMR Shareholding
31st Mar 20159:43 amRNSTotal Voting Rights
30th Mar 20152:50 pmRNSAnnual Financial Report
24th Mar 20153:21 pmRNSAdditional Listing
23rd Mar 20157:00 amRNSFinancial close reached on UK schools JV
13th Mar 201511:30 amRNSHolding(s) in Company
12th Mar 20157:00 amRNSInterserve JV wins GBP150m power plant contract
11th Mar 201510:12 amRNSDirector/PDMR Shareholding
4th Mar 20159:56 amRNSDirector/PDMR Shareholding
26th Feb 20157:05 amRNSChairman's intention to step down
26th Feb 20157:01 amRNSFinal Results
23rd Feb 20157:06 amRNSNick Salmon appointed Non-Exec Director of Acal
19th Feb 20157:00 amRNSNotice of Results
12th Feb 201511:43 amRNSDirector/PDMR Shareholding
2nd Feb 20154:04 pmRNSHolding(s) in Company
2nd Feb 20153:56 pmRNSHolding(s) in Company
27th Jan 201511:14 amRNSHolding(s) in Company
22nd Jan 20152:24 pmRNSHolding(s) in Company
16th Jan 20151:54 pmRNSDirector/PDMR Shareholding
7th Jan 20158:52 amRNSTrading Update
2nd Jan 20157:00 amRNSBlocklisting Interim Review
31st Dec 20147:00 amRNSTotal Voting Rights
19th Dec 201410:33 amRNSHolding(s) in Company
18th Dec 201410:38 amRNSProbation and rehabilitation services contracts
17th Dec 20143:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.